Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATX-101 for Submental Fat Reduction
NCT01305577Phase 3Completed
- Sponsor
- Kythera Biopharmaceuticals
- Start
- Dec 2010
- Primary completion
- Jan 2012
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 3 trial of sodium deoxycholate in submental fat, sponsored by Kythera Biopharmaceuticals. Started Dec 2010; status: completed.
02
Drugs
sodium deoxycholate
03
Conditions
submental fat
Beyond the preview
Go deeper on NCT01305577.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01305577.